Many microcaps that are having their clinical resultsanalysed by a third party will go into a trading halt between data lock and unblinding.I think the headset is better to be safe than sorry. So the explanation for the delay proposedhere makes perfect to me.
Reading the numerous posts here the main difference ofopinion I would have with them is peoples confidence in the reproducibility ofresults arising from “studies” as opposed to clinical trials.There is actually a world of difference between a study andtrial.
But on good results everyone can go about their daily livesand never give this another thought. On negative results there will be the question “why” – theanswer to which will nearly certainly involve getting your head around complicatedtrial methodology mumbo-jumbo which won’t make anyone one iota happier.So the first option is definitely the best one.
- Forums
- ASX - By Stock
- RAP
- Ann: Voluntary Suspension
Ann: Voluntary Suspension, page-274
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 217 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online